What Is Addyi, and Why Does It Matter? Addyi (flibanserin) is a nonhormonal prescription pill that is now approved by the FDA to treat low sexual desire in women younger than 65, including those who ...

Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since she started the medication Courtesy Debra Dillo There’s a pill on the ...

Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally entering the long-overdue conversation. The FDA recently approved the use ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? The "little pink pill" is now available to even more women. The Food and Drug ...

In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “Viagra ...

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old. The ...

Flibanserin (Addyi) is a Viagra-like drug for cisgender women and others assigned female at birth. Currently, Addyi is only available through certain prescribers and pharmacies. Addyi was approved by ...

Raleigh, N.C. - September 21, 2015 - Sprout Pharmaceuticals, Inc. (Sprout) announced today that healthcare prescribers and pharmacies can now complete training to become certified to prescribe or ...

PHIL expands direct-to-patient access to Addyi for as low as $40 per year with commercial insurance coverage or $149 per month cash whether accessed through telehealth or a doctor's office. The goal ...